THAP9-AS1: A Potential Drug Target and Biomarker (G100499177)

Target Name: THAP9-AS1

NCBI ID: G100499177

THAP9-AS1

Other Name(s): THAP9 antisense RNA 1 | THAP9 antisense RNA 1, transcript variant 1

THAP9-AS1: A Potential Drug Target and Biomarker

THAP9-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, lungs, and gastrointestinal tract. It is a member of the TATA-protein family, which is known for their role in gene regulation and DNA binding. THAP9-AS1 has been shown to play a role in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation.

In recent years, researchers have been interested in THAP9-AS1 as a potential drug target. This is because the protein has been shown to interact with a variety of small molecules, including drugs that are currently being used to treat a range of diseases. For example, studies have shown that THAP9-AS1 can interact with inhibitors of the protein kinase A (PKA), which is a key regulator of cell growth and apoptosis. These interactions may suggest that THAP9-AS1 could be a useful target for drugs that are currently being used to treat conditions such as cancer, neurodegenerative diseases, and autoimmune disorders.

In addition to its potential as a drug target, THAP9-AS1 has also been shown to be a potential biomarker. This is because the protein is expressed in a variety of tissues and can be easily isolated and quantified using techniques such as Western blotting. Studies have shown that THAP9-AS1 levels are elevated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This may suggest that THAP9-AS1 could be a useful biomarker for these conditions.

Furthermore, THAP9-AS1 has been shown to play a role in the regulation of cellular processes that are important for human health. For example, studies have shown that THAP9-AS1 is involved in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death. This may be important for the development and progression of many diseases, including cancer. Additionally, THAP9-AS1 has been shown to be involved in the regulation of cell proliferation, which is the process by which cells grow and divide. This may be important for the development and progression of many diseases, including neurodegenerative diseases.

In conclusion, THAP9-AS1 is a protein that has been shown to play a role in a variety of cellular processes that are important for human health. As a result, it is a potential drug target and biomarker. Further research is needed to fully understand the role of THAP9-AS1 in these processes and to develop treatments for diseases that are currently treated with limited options.

Protein Name: THAP9 Antisense RNA 1

The "THAP9-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about THAP9-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets